Evidence map›Paper›PMID 29178927›Full record

ArticleHarm reduction journal2017

Why is there still hepatitis C transmission in Australian prisons? A case report.

Ben Harkness, Michael Levy, Ruth Evans, Jillian Wenke

Abstract readCase Reports
In one paragraph

Article in Harm reduction journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ben HarknessJustice Health Services, ACT Health, Canberra, Australia. ben.harkness@act.gov.au.ORCID 0000-0001-6709-4636
Michael LevyJustice Health Services, ACT Health, ANU Medical School, Canberra, Australia.
Ruth EvansJustice Health Services, ACT Health, Canberra, Australia.
Jillian WenkeJustice Health Services, ACT Health, Canberra, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ability to cure hepatitis C viral infection, with specific reference to the prisoner population and the prison environment, will be challenged, even if opiate replacement therapy is concurrently offered, and even if bleach is available. The missing elements, widely available in the community, are a regulated injecting equipment exchange and tattooing parlours. CASE PRESENTATION: We report a case of re-infection of hepatitis C in a prisoner treated with a direct-acting antiviral. What makes this case so remarkable is that it was entirely predictable and preventable.

conclusionsHepatitis C infection will continue to test both the strengths and the weaknesses in the relationship between health and corrective services in Australia. Nothing less than full implementation of all harm minimisation modalities will be necessary to eliminate the clinical and public health risks of hepatitis C infection, both in prison and by extension into the general community.

Indexed as

PrisonsAdultAntiviral AgentsAustraliaHarm ReductionHepatitis CHumansMaleNeedle-Exchange ProgramsNeedle SharingPrisonersRecurrenceSubstance Abuse, IntravenousTattooingAntiviral AgentsDirect-acting antiviralsHepatitis CNeedle syringe programmePrisoner healthRe-infection

Identifiers

PMID29178927
PMCPMC5702208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.